[EN] N-(2-ARYLETHYL)BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR<br/>[FR] N-(2-ARYLETHYL)BENZYLAMINES UTILISEES EN TANT QU'ANTAGONISTES DU RECEPTEUR 5-HT6
申请人:LILLY CO ELI
公开号:WO2002078693A2
公开(公告)日:2002-10-10
The present invention provides compounds of formula (I), which are antagonists of the 5-HT6 receptor.
本发明提供了式(I)的化合物,它们是5-HT6受体的拮抗剂。
N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
申请人:Chen Zhaogen
公开号:US20060009511A9
公开(公告)日:2006-01-12
The present invention provides compounds of formula (I), which are antagonists of the 5-HT
6
receptor.
本发明提供了式(I)的化合物,它们是5-HT6受体的拮抗剂。
N-(2-ARYLETHYL) BENZYLAMINES AS ANTAGONISTS OF THE 5-HT6 RECEPTOR
申请人:ELI LILLY AND COMPANY
公开号:EP1379239A2
公开(公告)日:2004-01-14
Copper/Iodine Co-catalyzed Oxygenative Transannulation of Tryptamines Enables Direct Synthesis of Donaxaridine and Its Derivatives
transannulation strategy using readily available tryptamines. Molecular oxygen and water are used as oxygen sources and provide direct access to the donaxaridine scaffold and its derivatives. This methodology is applied to the efficient synthesis of the natural products donaxaridine, chimonamidine, donaxanine, donaxarine, and aline in just one or two steps. The tryptamines, albeit with oxy-sensitive dialkyl N-H